Provide requirements relating to clinician-administered drugs under the Pharmacy Benefit Manager Licensure and Regulation Act
This bill adds specific requirements for "clinician-administered drugs" (outpatient drugs that cannot be self-administered and must be given in clinics, hospitals, or similar settings by a healthcare provider) under Nebraska's Pharmacy Benefit Manager (PBM) regulations. It requires specialty pharmacies shipping these drugs to provide 24/7 pharmacist/nurse access, allow refill requests through PBMs/health plans, and comply with federal drug tracking rules. The bill also mandates that PBMs or health plans must establish a clear appeal process for providers if drugs aren't delivered on time or if urgent care is needed to prevent immediate harm. These changes directly affect specialty pharmacies, PBMs, and healthcare providers administering these drugs, effective January 2026.
Bill status
died
1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 22, 2025
Last action Apr 17, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
0
Committee
2
Apr 17, 2026
Committee
Indefinitely postponed
legislature
Jan 24, 2025
Committee
Referred to Banking, Commerce and Insurance Committee
legislature
Jan 22, 2025
Introduced
Date of introduction
legislature
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Kathleen Kauth
NNonpartisan
Ask Maddy
·
AI policy assistant
Ask Maddy about LB 533
Scope: NE
Hi! I can help you understand LB 533. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline